From: The value of serum IL-4 to predict the survival of MDS patients
Factors | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|
HR (95% CI) | P | HR (95% CI) | P | |
Male | 1.820 (0.560–5.915) | 0.319 |  |  |
Age ≥ 65 | 0.342 (0.120–0.973) | 0.044 | 0.362 (0.141–0.977) | 0.045 |
HB ≥ 100 g/L | 0.256 (0.032–2.045) | 0.199 |  |  |
N ≥ 0.8*109/L | 1.946 (0.525–7.208) | 0.319 |  |  |
PLT ≥ 100*109/L | 1.092 (0.379–3.144) | 0.870 |  |  |
Cytopenia series ≥ 2 | 0.211 (0.117–1.605) | 0.211 |  |  |
Bone marrow primitive cell ratio ≥ 2% | 0.736 (0.244–2.216) | 0.586 |  |  |
Karyotype: bad | 0.665 (0.236–1.876) | 0.441 |  |  |
IL-4 | 0.172 (0.061–0.487) | 0.001 | 0.237 (0.114–0.779) | 0.013 |